ISRCTN36001452已完成不适用
Ibopamine eye drops in the treatment of hypotony after vitreoretinal surgery in retinal detachment or uveitis
Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)0 个研究点目标入组 15 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Hypotony (0 - 5 mmHg)
- •2. Stable eye pressure for at least 4 months
- •3. No reaction of eye pressure to atropine and steroids
- •4. Continued steroid treatment during past six months
- •5. Status after vitreoretinal surgery or uveitis
排除标准
- •1. Chronic heart failure
- •2. Traction on corpus ciliare
- •3. Cyclodialysis
研究者
相似试验
已完成
不适用
Ibopamine eyedrops in the treatment of hypotony after vitreoretinal surgery in retinal detachment or uveitis.NL-OMON2646415
已完成
不适用
Ibopamine 2% eyedrops in the treatment of patients with ocular hypotony after vitreoretinal surgery for retinal detachment or uveitis; Results after six months of treatment.NL-OMON2128521
已完成
不适用
Ibopamine 2% eye drops in the treatment of patients with ocular hypotony after vitreoretinal surgery for retinal detachment or uveitis: results after six months of treatmentISRCTN46178243Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)17
招募中
1 期
Intravitreal Panitumumab for Prevention of Myopic Axial Elongation in Highly Myopic Adult Eyes with Myopic Macular DegeneratioMyopic ophthalmopathyDRKS00027302fa Eye Research Institute40
进行中（未招募）
1 期
Panitumumab to prevent the progression of eyeball elongation in adults with nearsightedness and macular degeneratioAdult highly myopic patients with myopic macular degenerationEye DiseasesISRCTN96896687fa Eye Research Institute20